{"name":"IBSS Biomed S.A.","slug":"ibss-biomed-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Td-Impfstoff Merieux","genericName":"Td-Impfstoff Merieux","slug":"td-impfstoff-merieux","indication":"Prevention of diphtheria and tetanus","status":"phase_3"},{"name":"Clodivac","genericName":"Clodivac","slug":"clodivac","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Td-Impfstoff Merieux","genericName":"Td-Impfstoff Merieux","slug":"td-impfstoff-merieux","phase":"phase_3","mechanism":"Td-Impfstoff Merieux is a vaccine that stimulates the body's immune response to diphtheria and tetanus.","indications":["Prevention of diphtheria and tetanus"],"catalyst":""},{"name":"Clodivac","genericName":"Clodivac","slug":"clodivac","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}